There are several lines of evidence that point to the role of insulin signaling in AD; e.g. insulin levels in the CSF of AD patients is lower than healthy controls [31,32], insulin receptor signaling is compromised in AD neurons [33], and insulin resistance is associated with reductions in cerebral glucose metabolic rate, which is a risk factor for developing AD dementia [34]. This evidence concerns the gene INSR and Alzheimer disease.